Ophthalmology Practice Data for Surgical Device Reps

The PE Consolidation Wave in Eye Care

Private equity's interest in ophthalmology started in the mid-2010s and has accelerated every year since. By 2025, PE-backed platforms own or manage an estimated 15-20% of ophthalmology practices nationally, with much higher penetration in certain markets.

The major platforms include:

• EyeCare Partners: One of the largest PE-backed eye care platforms, operating 600+ locations across 20+ states. Backed by Partners Group.
• VSP Vision (Vsp Ventures): The vision insurance giant also operates retail optical and eye care practices, creating a vertically integrated model that includes insurance, retail, and clinical services.
• US Eye: 70+ locations across the Southeast, focused on ophthalmology and optometry.
• Unifeye Vision Partners: 60+ locations, multi-state, focused on comprehensive eye care.
• Eye Health America: Growing rapidly through acquisitions in the mid-Atlantic and Southeast.
• Spectrum Vision Partners: 40+ locations, primarily in the Northeast.

Several dozen additional regional platforms operate with PE backing, each aggregating 5-30 practices. The pace of acquisitions shows no signs of slowing. For device reps, this consolidation fundamentally changes the sales motion.

What PE Consolidation Means for Device Sales

When EyeCare Partners acquires an independent ophthalmology practice, the surgeon who previously made equipment decisions now reports to a corporate structure. Capital equipment purchases above a certain threshold (typically $25,000-$100,000) require corporate approval. Vendor contracts are negotiated centrally. A surgeon who loved your IOL lens at their independent practice may no longer be able to choose your product after their practice joins a PE platform.

This creates three distinct sales challenges:

1. Finding the right level: The surgeon is your clinical champion. The corporate VP of Procurement is your buyer. You need relationships with both.
2. Tracking ownership changes: An independent practice you sold to last year may now be PE-owned. Your contact strategy needs to adapt.
3. Competing for platform-wide contracts: A PE platform deal might cover 50+ surgical locations. The stakes are higher, the competition is stiffer, and the sales cycle is longer.

Data Fields That Drive Ophthalmology Device Sales

When building your ophthalmology prospect list, these data fields separate productive outreach from wasted effort:

• Sub-specialty classification: Cataract/refractive, retina, glaucoma, cornea, oculoplastics, general/complete, neuro-ophthalmology. NPI taxonomy codes distinguish ophthalmology from optometry but do not reliably distinguish sub-specialties within ophthalmology. Enrichment from practice websites, hospital privileges, and fellowship training is required.
• Surgical status: Does this provider actively perform surgery? Not all ophthalmologists do. Some have transitioned to medical-only practice. ASC affiliation and surgical privileges data confirm active surgical status.
• ASC affiliation: Which ambulatory surgery center(s) does the ophthalmologist operate at? This is critical for surgical equipment sales. The ASC is often the purchasing entity for shared surgical equipment, not the individual practice.
• Ownership structure: Independent practice, PE-backed platform, hospital-employed, or academic. This determines the decision-making path and sales cycle.
• PE platform identification: If PE-backed, which platform? EyeCare Partners locations buy differently than US Eye locations. Platform-level contacts are essential.
• Practice size (provider count): A 6-surgeon cataract practice has very different volume and equipment needs than a solo complete ophthalmologist.
• Decision-maker contacts: Managing partner, practice administrator, surgical coordinator, ASC director. Multiple contacts enable multi-threaded selling.
• Procedure volume indicators: High cataract volume practices (1,000+ cases/year) are premium prospects for IOL and phaco equipment companies.

Provyx builds eye care practice datasets with sub-specialty classification, ASC affiliation, ownership intelligence, and decision-maker contacts for device sales teams.

Building Territory Plans for Ophthalmic Device Sales

Step 1: Define Your Product-Market Segment

Which eye care providers need your product?

• IOL manufacturers: High-volume cataract surgeons, primarily at ASCs. Target surgeons performing 500+ cases per year.
• Phaco/femto laser companies: ASCs and large ophthalmology practices with surgical suites. Focus on facilities with equipment older than 7 years for replacement cycle targeting.
• Diagnostic equipment (OCT, visual fields): All ophthalmology and optometry practices. Broader market, lower price point, shorter sales cycle.
• Retinal imaging and treatment: Retina subspecialty practices and multi-specialty groups with retina divisions. Narrower market, higher price point.
• LASIK platforms: Refractive surgery centers. Very narrow market (roughly 700-1,000 active LASIK centers), very high deal value.

Step 2: Segment by Ownership and Buying Process

Divide your prospects into three tiers:

• Tier 1: Independent surgical practices and surgeon-owned ASCs. Fastest sales cycle, direct relationship with the surgeon-buyer. These should be your highest-activity outreach segment.
• Tier 2: Small PE platforms and regional groups (5-30 locations). Semi-centralized purchasing. You may need both the local surgeon champion and a regional or corporate operations contact.
• Tier 3: Large PE platforms (EyeCare Partners, etc.) and health systems. Fully centralized purchasing. Enterprise sales motion. Corporate-level contacts required. Higher deal value but 6-12 month cycles.

Step 3: Map ASC Relationships

For surgical equipment specifically, overlay ASC data onto your practice data. Identify which surgeons operate at which ASCs, and whether those ASCs are surgeon-owned or independently operated. This determines whether you need one relationship (surgeon-owner) or two (surgeon plus ASC administrator).

Step 4: Prioritize by Procedure Volume and Equipment Age

If your data includes procedure volume indicators (from claims data or practice size proxies) and equipment age estimates (from practice tenure or known installation dates), you can prioritize the highest-volume practices with the oldest equipment. These are your best prospects for capital equipment replacement.

Step 5: Assign Territories with Account Complexity Weighting

Don't assign territories by location count alone. A territory with 30 independent practices is a lighter workload than a territory with 5 PE-backed groups covering 100 locations. Weight territories by the complexity and value of the accounts, not just the count.

PE Platform Intelligence: What Your Data Should Include

Given the scale of PE consolidation in eye care, your ophthalmology dataset needs platform-level intelligence that goes beyond flagging "PE-backed." Useful data points include:

• Platform name: Which PE-backed group owns or manages this practice?
• Platform size: Total location count, geographic footprint, provider count.
• PE sponsor: Which PE firm backs the platform? Knowing the financial sponsor helps your enterprise team understand the platform's growth trajectory and capital allocation priorities.
• Acquisition recency: Was this practice acquired recently (still integrating) or years ago (fully integrated into corporate procurement)? Recently acquired practices may still have some local purchasing autonomy during the transition period.
• Corporate contacts: VP of Operations, VP of Procurement, Chief Medical Officer, CFO at the platform level. These are your enterprise sale contacts.

Understanding PE dynamics in healthcare is critical for any device sales organization. Our PE healthcare data guide covers how consolidation affects sales strategies across multiple specialties.

Getting Started with Ophthalmology Practice Data

If you're building or rebuilding your ophthalmology territory plan, start with these steps:

1. Define your product-market segment. Surgical equipment? Diagnostic devices? Specific sub-specialty focus?
2. Source ophthalmology-specific data with sub-specialty classification, ASC affiliation, and ownership intelligence. Generic healthcare databases that lump all eye care together won't give you the segmentation you need.
3. Map PE platform relationships and build separate contact strategies for independent practices vs. Corporate-level engagement.
4. Overlay ASC data to identify where surgical equipment decisions are actually made.
5. Establish a quarterly refresh cadence to capture the ongoing acquisition activity in eye care.

Provyx delivers eye care provider data with the depth needed for surgical device sales: sub-specialty segmentation, ASC mapping, PE platform identification, and verified decision-maker contacts at both the practice and corporate level.